Kanzhun
BZ · NASDAQ
About BZ
- Employees
- 4,884
- Headquarters
- Beijing, Beijing
- Listed
- Jun 11, 2021
- Sector
- Industrials
- Industry
- Professional Services
- Website
- ir.zhipin.com
BZ key statistics
- Market cap
- 7.52B
- Price-earnings ratio
- 22.79
- Dividend yield
- —
- Average volume
- 4.85M
- Volume
- 3.94M
- Open price
- $16.51
- High today
- $16.67
- Low today
- $16.33
- 52 Week high
- $22.81
- 52 Week low
- $12.57
Kanzhun (BZ) at a glance
As of Oct 23, 2026, Kanzhun (BZ) shares are priced at $16.46, giving the company a market cap of 7.52B and a price-to-earnings ratio of 22.79.
Today the stock has traded between $16.33 and $16.67. The current price is 0.8% above the day's low and 1.3% below its high.
Volume so far is 3.94M shares, in line with the average of 4.85M shares a day.
Over the past year Kanzhun has ranged from $12.57 to $22.81, and now sits 38% of the way up that range.
Kanzhun met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $2.23 per share against an estimate of $2.19.
The average analyst price target is $22.58, 37.2% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $17.17
- Now
- $16.46
- High
- $28.35
BZ earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 5.9% on average.
- Q3 FY24: reported $1.64 per share against an estimate of $1.50
- Q4 FY24: reported $1.58 per share against an estimate of $1.59
- Q1 FY25: reported $1.72 per share against an estimate of $1.61
- Q2 FY25: reported $2.09 per share against an estimate of $1.90
- Q3 FY25: reported $2.16 per share against an estimate of $2.13
- Q4 FY25: reported $1.90 per share against an estimate of $1.99
- Q1 FY26: reported $1.87 per share against an estimate of $1.78
- Q2 FY26: reported $2.23 per share against an estimate of $2.19
BZ news
- Bamboo Works
A Preview Of Kanzhun's Earnings
Insights Ahead: Kanzhun's Quarterly Earnings
- Press releasePRNewswire
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
- Lekha Gupta
Chinese Stocks Dominate Mid Cap Space - Bilibili And XPeng Are Among Top 7 Mid Cap Gainers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
- Avi Kapoor
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
- Avi Kapoor
Wave Life Sciences, Nio, Li Auto, Tesla And Other Big Stocks Moving Higher On Tuesday
- The Bamboo Works
Kanzhun Works Investors Into Selling Frenzy With Talk Of 'Challenging Times'
Similar companies
Companies in the same industry as Kanzhun
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.